154 related articles for article (PubMed ID: 32203293)
1. The pandemic pipeline.
Hodgson J
Nat Biotechnol; 2020 May; 38(5):523-532. PubMed ID: 32203293
[No Abstract] [Full Text] [Related]
2. Audio Interview: Approaches to Covid-19 Vaccines and Antivirals.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2020 Apr; 382(16):e58. PubMed ID: 32320592
[No Abstract] [Full Text] [Related]
3. COVID-19: Small-Molecule Clinical Trials Landscape.
Ferreira LLG; Andricopulo AD
Curr Top Med Chem; 2020; 20(18):1577-1580. PubMed ID: 32862824
[No Abstract] [Full Text] [Related]
4. News Feature: To counter the pandemic, clinicians bank on repurposed drugs.
Madhusoodanan J
Proc Natl Acad Sci U S A; 2020 May; 117(20):10616-10620. PubMed ID: 32350142
[No Abstract] [Full Text] [Related]
5. COVID-19: A Defining Moment for Clinical Pharmacology?
van der Graaf PH; Giacomini KM
Clin Pharmacol Ther; 2020 Jul; 108(1):11-15. PubMed ID: 32350861
[No Abstract] [Full Text] [Related]
6. Critical Need for Implementation of Clinical Pharmacology Principles in Developing Drugs for the Treatment or Prevention of COVID-19.
Pastino G
J Clin Pharmacol; 2020 Aug; 60(8):979. PubMed ID: 32535939
[No Abstract] [Full Text] [Related]
7. NIH organizes hunt for drugs.
Kaiser J
Science; 2020 Apr; 368(6489):351. PubMed ID: 32327575
[No Abstract] [Full Text] [Related]
8. Drug Repurposing Study Pinpoints Potential COVID-19 Antivirals.
Abbasi J
JAMA; 2020 Sep; 324(10):928. PubMed ID: 32897326
[No Abstract] [Full Text] [Related]
9. Tracking a Vaccine and Developing Therapeutics for COVID-19.
Gould KA
Dimens Crit Care Nurs; 2020; 39(6):293-297. PubMed ID: 33009266
[No Abstract] [Full Text] [Related]
10. Uncertainty about the Efficacy of Remdesivir on COVID-19.
Yoo JH
J Korean Med Sci; 2020 Jun; 35(23):e221. PubMed ID: 32537956
[No Abstract] [Full Text] [Related]
11. [SARS-CoV-2 protease: an excellent target to develop drugs against COVID-19].
Ladoux A; Azoulay S; Dani C
Med Sci (Paris); 2020; 36(6-7):555-558. PubMed ID: 32558640
[No Abstract] [Full Text] [Related]
12. Harnessing the power of novel animal-free test methods for the development of COVID-19 drugs and vaccines.
Busquet F; Hartung T; Pallocca G; Rovida C; Leist M
Arch Toxicol; 2020 Jun; 94(6):2263-2272. PubMed ID: 32447523
[TBL] [Abstract][Full Text] [Related]
13. Psychiatry and COVID-19: The Role of Chlorpromazine.
Stip E
Can J Psychiatry; 2020 Oct; 65(10):739-740. PubMed ID: 32536208
[No Abstract] [Full Text] [Related]
14. Dozens of coronavirus drugs are in development - what happens next?
Ledford H
Nature; 2020 May; 581(7808):247-248. PubMed ID: 32409766
[No Abstract] [Full Text] [Related]
15. A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance.
Ahn BY; Kang CK; Seo JD; Choe PG; Song SH; Park WB; Park SW; Kim NJ; Oh MD
J Korean Med Sci; 2020 Jun; 35(24):e231. PubMed ID: 32567262
[TBL] [Abstract][Full Text] [Related]
16. COVID-19: Wait for a novel drug or act with the age old drug - Do we have a choice?
Thangaraju P; Gurunthalingam MP; Venkatesan S; Thangaraju E
J Infect Public Health; 2020 Jun; 13(6):899-900. PubMed ID: 32451256
[No Abstract] [Full Text] [Related]
17. Cationic drugs and COVID-19.
Brenna OV; Torretta S; Pignataro L; Di Berardino F
Int J Immunopathol Pharmacol; 2020; 34():2058738420966078. PubMed ID: 33045858
[TBL] [Abstract][Full Text] [Related]
18. Covid-19: From structure to therapeutic targeting in studying approved drugs and local DNA vaccination.
Wang Z; Hong X; Wang H; Liu J; Liu JP
Clin Exp Pharmacol Physiol; 2020 Nov; 47(11):1771-1773. PubMed ID: 32976637
[No Abstract] [Full Text] [Related]
19. The Landscape of Prescription Drug Shortages During the COVID-19 Pandemic.
Fox ER; Stolbach AI; Mazer-Amirshahi M
J Med Toxicol; 2020 Jul; 16(3):311-313. PubMed ID: 32458230
[No Abstract] [Full Text] [Related]
20. COVID-19: An Update on Clinical Trials.
Kumar Y; Singh AK; Kumar S
Curr Top Med Chem; 2020; 20(17):1516-1517. PubMed ID: 32394841
[No Abstract] [Full Text] [Related]
[Next] [New Search]
